Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations

• Principais autores: M. V. Sura (Autor), T. N. Ignatova (Autor), N. S. Rudneva (Autor), Yu. N. Sukhanova (Autor), N. G. Ulyanova (Autor), A. S. Khudyaev (Autor), V. A. Shelyakin (Autor), D. V. Scherbakov (Autor)
• Formato: Livro
• Publicado em: IRBIS LLC, 2018-08-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

The existing model of financial support of medical assistance for clinical-statistical groups (CSGs) in 2018 provides for the reimbursement for hospital stay expenses by the compulsory medical insurance fund in patients claiming the need for genetically engineered biological products (GiBP) during t...